Niacin/Laropiprant Products to Be Withdrawn in EU Next WeekNiacin/Laropiprant Products to Be Withdrawn in EU Next Week

The Committee for the Medicinal Products of Human Use of the European Medicines Agency has followed the advice of its pharmacovigilance risk assessment team and confirmed it will recommend suspension of niacin/laropiprant products. Doctors should no longer prescribe the agents, which will cease to be available in the EU as of next week. News Alerts
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Alert Source Type: news